N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Hand and Foot Syndrome
Both
Hand and Foot Syndrome
Trial Information
Inclusion Criteria:
- Any adult patient starting capecitabine-containing chemotherapy
- Has never had capecitabine before
- Performance status 0-2 using the ECOG classification
- Life expectancy more than 6 months
- Agreed to stop any vitamin supplements, apart from vitamin D.
- Liver function studies including AST/ALT within 3x upper limit of normal
- Signed informed consent must be obtained from participating individuals
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Outcome Measure:
To determine the incidence of vitamine B6 in patient receiving vitamin b6
Outcome Time Frame:
1 year
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
08-069
NCT ID:
NCT00767689
Start Date:
May 2008
Completion Date:
May 2010
Related Keywords:
- Hand and Foot Syndrome
Name | Location |
|---|---|
| John H Stroger Jr Hospital of Cook County | Chicago, Illinois 60612-3785 |
